Accesso libero

Short cognitive screening in elderlies as a part of advanced pharmaceutical care in Slovak community pharmacies - The pilot study KOGNIMET-SK

Z. Mačeková

Z. Mačeková

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in BratislavaSlovak Republic
  • Hospital Pharmacy, Nemocnica AGEL Košice-Šaca a.s.Slovak Republic
Cerca questo autore su
Sciendo|Google Scholar
Mačeková, Z.
, 
M. Krivošová

M. Krivošová

Biomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University in BratislavaSlovak Republic
Cerca questo autore su
Sciendo|Google Scholar
Krivošová, M.
, 
T. Fazekaš

T. Fazekaš

Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University in BratislavaSlovak Republic
Cerca questo autore su
Sciendo|Google Scholar
Fazekaš, T.
, 
M. Snopková

M. Snopková

Department of Organisation and Management of Pharmacy, Faculty of Pharmacy, Comenius University in BratislavaSlovak Republic
Cerca questo autore su
Sciendo|Google Scholar
Snopková, M.
 e 
J. Klimas

J. Klimas

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in BratislavaSlovak Republic
Cerca questo autore su
Sciendo|Google Scholar
Klimas, J.
  
24 giu 2022
Short cognitive screening in elderlies as a part of advanced pharmaceutical care in Slovak community pharmacies - The pilot study KOGNIMET-SK's Cover Image
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Cita
Scarica la copertina
Categoria dell'articolo: Original Paper
Pubblicato online: 24 giu 2022
Pagine: 37 - 42
Ricevuto: 14 feb 2022
Accettato: 03 mag 2022
DOI: https://doi.org/10.2478/afpuc-2022-0005
Parole chiave
© 2022 Mačeková Z. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1

Concurrent occurrences of various MetS components and their incidence rate in study cohort (N, %).
Concurrent occurrences of various MetS components and their incidence rate in study cohort (N, %).

MoCA mean score with presence or absence of individual MetS components_

MoCA score ± SD p value MoCA score ± SD p value
All
MetS components Presence Absence Male Female
Abdominal obesity 23.6 ± 3.4 24.5 ± 3.6 0.061 24.1 ± 3.2 23.3 ± 3.5 0.243
Hypertension 23.6 ± 3.6 24.9 ± 3.1 <0.05 23.7 ± 3.3 23.5 ± 3.8 0.774
Dyslipidaemias 23.5 ± 3.7 24.2 ± 3.4 0.227 25.7 ± 1.2 23.3 ± 4.0 0.251
Type 2 diabetes mellitus 23.6 ± 3.2 24.0 ± 3.6 0.500 24.5 ± 2.7 22.8 ± 3.5 0.149

Baseline characteristics of study cohort_

Characteristics
Participants number 222
Age, mean (SD) 69 ± 6.3
Female, N (%) 141 (64)
Male, N (%) 81 (36)
Abdominal obesity, N (%) 134 (60)
Hypertension, N (%) 151 (68)
Type 2 diabetes mellitus, N (%) 31 (14)
Dyslipidaemias, N (%) 57 (26)
sMetS according to IDF 2006, N (%) 42 (19)
Smoking, N (%) 32 (14)
Sedentary lifestyle, N (%) 90 (41)
MoCA score, mean (SD) 24.0 (3.5)
MoCA score ≤ 24, N (%) 91 (41)
Lingua:
Inglese
Frequenza di pubblicazione:
2 volte all'anno
Argomenti della rivista:
Farmacia, Farmacia, altro
Feed RSS della rivista